Clinical Trial

Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection

Study acronym: SHIELD 1
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main goal of this project is to see if RADAR (Rapid AI-assisted Detection and Analysis of Rheumatic heart disease), which is a machine and deep-learning AI model, can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-14.
Trial Details
NCT Number NCT07599956
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: Uganda Heart Institute, Ochsner Health System, Vanderbilt University Medical Center, Children's National Health Center
Conditions Rheumatic Heart Disease
Enrollment 62 participants
Start Date 2026-06
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-27